Literature DB >> 8596636

Bax-independent inhibition of apoptosis by Bcl-XL.

E H Cheng1, B Levine, L H Boise, C B Thompson, J M Hardwick.   

Abstract

The Bcl-2-related protein, Bcl-XL, has been shown to block apoptosis induced by a variety of stimuli and to be a stronger protector against apoptosis than Bcl-2 under certain circumstances. Using site-specific mutagenesis, we show here that the amino-acid residues critical for protection of cells by Bcl-XL against Sindbis virus-induced apoptosis are clustered within the Bcl-2-homology regions 1 and 2 (BH1 and BH2 regions). The residues necessary for Bcl-XL function are not identical to those required for Bcl-2 function. Although it has been suggested that heterodimerization between Bcl-XL and Bax is essential for the anti-death activity of Bcl-XL (refs 7,8), our results suggest that the interaction with Bax is not required for Bcl-XL to exert its death-repressing activity. Specific mutations that disrupt the ability of Bcl-XL to interact with Bax or Bak still preserve 70-80% of the anti-death activity of wild-type Bcl-XL.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8596636     DOI: 10.1038/379554a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  121 in total

1.  Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins.

Authors:  D S Bellows; B N Chau; P Lee; Y Lazebnik; W H Burns; J M Hardwick
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Modeled microgravity inhibits apoptosis in peripheral blood lymphocytes.

Authors:  D Risin; N R Pellis
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-02       Impact factor: 2.416

3.  Effect of enforced expression of human bcl-2 on Japanese encephalitis virus-induced apoptosis in cultured cells.

Authors:  C L Liao; Y L Lin; J J Wang; Y L Huang; C T Yeh; S H Ma; L K Chen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis.

Authors:  Jae Myun Lee; Kyoung-Ho Lee; Magdalena Weidner; Barbara A Osborne; S Diane Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

5.  Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.

Authors:  Tae Woo Kim; Chien-Fu Hung; Morris Ling; Jeremy Juang; Liangmei He; J Marie Hardwick; Sharad Kumar; T-C Wu
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

6.  Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria.

Authors:  Damien Arnoult; Laura M Bartle; Anna Skaletskaya; Delphine Poncet; Naoufal Zamzami; Peter U Park; Juanita Sharpe; Richard J Youle; Victor S Goldmacher
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

7.  Bcl-2 homodimerization involves two distinct binding surfaces, a topographic arrangement that provides an effective mechanism for Bcl-2 to capture activated Bax.

Authors:  Zhi Zhang; Suzanne M Lapolla; Matthew G Annis; Mary Truscott; G Jane Roberts; Yiwei Miao; Yuanlong Shao; Chibing Tan; Jun Peng; Arthur E Johnson; Xuejun C Zhang; David W Andrews; Jialing Lin
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

8.  Active Bax and Bak are functional holins.

Authors:  Xiaming Pang; Samir H Moussa; Natalie M Targy; Jeffrey L Bose; Nicholas M George; Casey Gries; Hernando Lopez; Liqiang Zhang; Kenneth W Bayles; Ry Young; Xu Luo
Journal:  Genes Dev       Date:  2011-10-17       Impact factor: 11.361

9.  Noncanonical cytoplasmic processing of viral microRNAs.

Authors:  Jillian S Shapiro; Andrew Varble; Alissa M Pham; Benjamin R Tenoever
Journal:  RNA       Date:  2010-09-14       Impact factor: 4.942

10.  BCL-2 and BAX protect adult mice from lethal Sindbis virus infection but do not protect spinal cord motor neurons or prevent paralysis.

Authors:  Douglas A Kerr; Thomas Larsen; Susan H Cook; Yih-Ru Fannjiang; Eunkyung Choi; Diane E Griffin; J Marie Hardwick; David N Irani
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.